HORMONE PRECISIONMED
Area: MOST Inno Zone
Booth No: N915
Exhibitor Profile
Second-generation hormone drugs have improved prostate cancer survival. Despite this, resistance development time varies among patients. Using transcriptome chips, we analyzed peripheral blood prior to treatment. Weighted gene correlation network analysis and machine learning models achieved 84.5% and 90% accuracy for responses to androgen synthesis inhibitors and androgen receptor blockers, respectively. A patent has been obtained in Taiwan, with US, EU, and CN applications submitted.
Exhibitors you may be interested in
Highest Rated